Aura Biosciences grants COO 265K options, 135K RSUs
Aura COO Susan Abu‑Absi received inducement RSUs and stock options that vest over years, including RSUs starting Sept. 15, 2027 and options beginning Aug. 10, 2027.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Aura Biosciences, Inc. (AURA) reported that Chief Operating Officer Susan Abu‑Absi received equity awards on 2026-09-01. She was granted 265,487 stock options with an exercise price of $7.43 per share, expiring on 2036-09-01, and 134,513 RSUs as an inducement award. The RSUs vest in four substantially equal annual installments starting on September 15, 2027, and the options vest 25% on August 10, 2027 with the remainder vesting pro rata in 36 monthly installments, in each case subject to continued service.
Insider Trade Summary
Grant/Award: 400,000 shares
Grant/Award
2 txns
Insider
Abu-Absi Susan
Role
Chief Operating Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) F2 | 265,487 | $0.00 | $0.00 |
| Grant/Award | Common Stock F1 | 134,513 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 265,487 contracts (Direct);
Common Stock — 134,513 shares (Direct)
Footnotes (2)
- F1. These securities represent an inducement award granted pursuant to a restricted stock unit ("RSU") award agreement with the Issuer. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments, subject to the Reporting Person's continued service as of the relevant vesting date, with the first tranche scheduled to vest on September 15, 2027.
- F2. The option shall vest as follows: 25% of the options vest on August 10, 2027 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date.
Key Figures
RSUs granted: 134,513 RSUs
Stock options granted: 265,487 options
Option exercise price: $7.43 per share
+4 more
7 metrics
RSUs granted
134,513 RSUs
Inducement award to COO Susan Abu-Absi on 2026-09-01
Stock options granted
265,487 options
Grant to COO Susan Abu-Absi on 2026-09-01
Option exercise price
$7.43 per share
Exercise price for 265,487 stock options
Option expiration date
2036-09-01
Expiration of stock options granted on 2026-09-01
RSU vesting start date
September 15, 2027
First of four substantially equal annual RSU vesting dates
Initial option vesting
25% on August 10, 2027
First vesting tranche of stock options
Remaining option vesting period
36 monthly installments
Remaining options vest pro rata after initial 25% tranche
Key Terms
restricted stock unit ("RSU"), inducement award, vesting, stock option, +1 more
5 terms
restricted stock unit ("RSU") financial
"These securities represent an inducement award granted pursuant to a restricted stock unit ("RSU") award agreement"
inducement award financial
"These securities represent an inducement award granted pursuant to a restricted stock unit ("RSU") award agreement"
An inducement award is a special cash or equity payment given to a new hire—often an executive or key employee—outside the company’s regular pay plans to persuade them to join. Think of it like a signing bonus that can align the new person’s goals with shareholders but also represents a cost and can reduce existing owners’ percentage of the company, so investors watch these awards for their impact on ownership and future performance.
vesting financial
"These RSUs vest in four substantially equal annual installments, subject to the Reporting Person's continued service"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
stock option financial
"The option shall vest as follows: 25% of the options vest on August 10, 2027"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
exercise price financial
"conversion_or_exercise_price": "7.4300""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did AURA grant to COO Susan Abu-Absi on 2026-09-01?
On 2026-09-01, Susan Abu-Absi received 134,513 RSUs and 265,487 stock options in Aura Biosciences, Inc. The options have an exercise price of $7.43 per share and an expiration date of 2036-09-01, all held as direct ownership.
What is the vesting schedule for the new RSUs granted by AURA (AURA)?
The 134,513 RSUs granted as an inducement award vest in four substantially equal annual installments, subject to Susan Abu-Absi’s continued service, with the first tranche scheduled to vest on September 15, 2027.
How do the newly granted AURA stock options to the COO vest?
The 265,487 stock options vest as follows: 25% vest on August 10, 2027, and the remaining 75% vest pro rata in 36 monthly installments thereafter, subject to continued service on each vesting date.
What is the exercise price and expiration date of the AURA options granted?
The options granted to Susan Abu-Absi have an exercise price of $7.43 per share and an expiration date of 2036-09-01. Each option is a right to buy one share of Aura Biosciences, Inc. common stock upon vesting and exercise.
AI-generated analysis. How Rhea-AI works. Not financial advice.
